Media Room
New collaboration with Signal Genetics
June 29, 2011
New Collaboration with Signal Genetics, valued at US$ 13.3M, for the commercialization of PrevistageTM GCC
New publication on GCC's prognostic value
May 6, 2011
New Study: the PCA3 test could be useful to predict the outcome of an initial prostate biopsy
April 22, 2010
Video
Corporate Information
Logos
- DiagnoCure – Color (PNG)
- DiagnoCure – Black & White (PNG)
Contact
Geneviève Couture
Coordonator, Administration and Communication
(418) 527-6100
communications@diagnocure.com


